Irradiation of localized prostate cancer in the elderly: A systematic literature review

Irradiation of localized prostate cancer in the elderly: A systematic literature review

Purpose: To analyze the literature that addresses radiation therapy for intermediate and high-risk prostate cancer (PC) in the elderly. Patients and methods: A PubMed literature search was conducted including articles from 01/01/2000 to 30/06/21, with the following keywords: PC, radiotherapy/brachyt...

Full description

Bibliographic Details
Main Authors:	Delphine Marotte, Marie-Eve Chand-Fouche, Rabia Boulahssass, Jean-Michel Hannoun-Levi
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	Clinical and Translational Radiation Oncology
Subjects:	Prostate cancer Elderly Radiation therapy Brachytherapy Androgen deprivation therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405630822000301

Similar Items

High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort
by: Delphine Marotte, et al.
Published: (2022-07-01)

Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer
by: D. Baron, et al.
Published: (2023-11-01)

Secondary bladder and colorectal cancer after treatments for prostate cancer: A population based study
by: Patricia Grisel Quintana Bárcena, et al.
Published: (2024-02-01)

Potential Risk of Other-Cause Mortality Due to Long-Term Androgen Deprivation Therapy in Elderly Patients with Clinically Localized Prostate Cancer Treated with Radiotherapy—A Confirmation Study
by: Hideya Yamazaki, et al.
Published: (2020-07-01)

Triple combination therapy for clinically nonmetastatic super‐high‐risk prostate cancer
by: Koji Yoshimura, et al.
Published: (2022-07-01)

Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities
by: A. Gomez-Iturriaga, et al.
Published: (2024-03-01)

Iodine-125 brachytherapy and robotic stereotactic radiotherapy — treatment options for patients with localized prostate cancer
by: E. A. Kiprijanov, et al.
Published: (2021-12-01)

Incidence of prostate cancer in transgender women undergoing androgen deprivation therapy: A review
by: Saurabh Tyagi, et al.
Published: (2023-01-01)

Testosterone castration levels in patients with prostate cancer: Is there a difference between GnRH agonist and GnRH antagonist? Primary results of an open-label randomized control study
by: Vaios-Konstantinos Mytilekas, et al.
Published: (2023-11-01)

Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review
by: Tae Jin Kim, et al.
Published: (2021-03-01)

Novel Strategies for Treating Castration-Resistant Prostate Cancer
by: David Ka-Wai Leung, et al.
Published: (2021-03-01)

Cardiovascular Complications in Patients with Prostate Cancer: Potential Molecular Connections
by: Sooraj Kakkat, et al.
Published: (2023-04-01)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
by: Maree Pechlivanis, et al.
Published: (2021-12-01)

Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2
by: Maryam Labaf, et al.
Published: (2022-11-01)

Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group
by: Motohiro Murakami, et al.
Published: (2020-06-01)

Recent Advances in Advance Prostate Cancer
by: Nishant Lohia
Published: (2022-12-01)

Impact of androgen deprivation therapy on cognitive function in men with prostate cancer
by: Yutaka Yamamoto, et al.
Published: (2024-03-01)

Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)
by: Melissa Gamat-Huber, et al.
Published: (2020-09-01)

Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy
by: Jennifer L. Kalina, et al.
Published: (2017-01-01)

Cancer Therapy–Related Cardiac Dysfunction in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
by: Dong‐Yi Chen, et al.
Published: (2023-10-01)

Cardiometabolic and Skeletal Risk Factors in Black Men with Prostate Cancer Starting Androgen Deprivation Therapy
by: Orvar Gunnarsson, et al.
Published: (2015-04-01)

Serum testosterone level predicts the effective time of androgen deprivation therapy in metastatic prostate cancer patients
by: Yue Wang, et al.
Published: (2017-01-01)

Should We Reconsider the Necessity of a Refinement of Prostate Cancer Risk Classification and Radiotherapy Treatment Strategy? Experiences from a Retrospective Analysis of Data from a Single Institution
by: Viktória Temesfői, et al.
Published: (2020-12-01)

Exercise Adherence in Men with Prostate Cancer Undergoing Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis
by: Kellie Toohey, et al.
Published: (2022-05-01)

Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
by: Tore Bach-Gansmo, et al.
Published: (2022-06-01)

Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
by: Norman J. Maitland
Published: (2021-01-01)

Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
by: Iván Henríquez, et al.
Published: (2021-09-01)

Hormonal Therapies for Patients with Advanced Prostate Cancer
by: Cora N. Sternberg, et al.
Published: (2016-01-01)

Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT
by: Zeina Ayoub, et al.
Published: (2022-12-01)

Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
by: Hisham F. Bahmad, et al.
Published: (2022-02-01)

Prostate Cancer, Treatment and Response of the Hematological System in Mexican Population
by: Shaila Cejudo-Arteaga, et al.
Published: (2023-07-01)

Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer
by: Nitya V. Sharma, et al.
Published: (2018-10-01)

Analysis of factors related to osteoporotic vertebral fracture in prostate cancer patients
by: Shunfa Huang, et al.
Published: (2024-02-01)

Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
by: Jean-Michel Hannoun-Levi, et al.
Published: (2022-11-01)

Simulation of an HDR “Boost” with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study
by: Jill S. Remick, MD, et al.
Published: (2020-11-01)

SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?
by: Kato Rans, et al.
Published: (2022-12-01)

Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone
by: Francesco A. Mistretta, et al.
Published: (2022-05-01)

AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy
by: Mads Dochedahl Winther, et al.
Published: (2020-07-01)

Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy
by: Chi-Shin Tseng, et al.
Published: (2021-05-01)

How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?
by: Turco F, et al.
Published: (2023-01-01)